BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25563153)

  • 1. [Prescription drug monitoring programs in the United States of America].
    El Burai Félix S; Mack K
    Rev Panam Salud Publica; 2014 Oct; 36(4):270-6. PubMed ID: 25563153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drug monitoring and dispensing of prescription opioids.
    Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G
    Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of abuse among unintentional pharmaceutical overdose fatalities.
    Hall AJ; Logan JE; Toblin RL; Kaplan JA; Kraner JC; Bixler D; Crosby AE; Paulozzi LJ
    JAMA; 2008 Dec; 300(22):2613-20. PubMed ID: 19066381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.
    Worley J
    Issues Ment Health Nurs; 2012 May; 33(5):319-28. PubMed ID: 22545639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flood of opioids, a rising tide of deaths.
    Okie S
    N Engl J Med; 2010 Nov; 363(21):1981-5. PubMed ID: 21083382
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription of opioid analgesics and related harms in Australia.
    Roxburgh A; Bruno R; Larance B; Burns L
    Med J Aust; 2011 Sep; 195(5):280-4. PubMed ID: 21895598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.
    Deyo RA; Irvine JM; Millet LM; Beran T; O'Kane N; Wright DA; McCarty D
    Health Aff (Millwood); 2013 Mar; 32(3):603-13. PubMed ID: 23406570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the present state and potential of Medicaid controlled substance lock-in programs.
    Roberts AW; Skinner AC
    J Manag Care Spec Pharm; 2014 May; 20(5):439-46c. PubMed ID: 24761815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
    Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
    J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients.
    De Marco Centeno P; Baig M; Lee SE; Lane CJ; Lagomasino IT
    J Psychiatr Pract; 2015 Nov; 21(6):412-8. PubMed ID: 26554323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
    Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
    N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drug abuse: problem, policies, and implications.
    Phillips J
    Nurs Outlook; 2013; 61(2):78-84. PubMed ID: 23245611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013.
    Berecki-Gisolf J; Hassani-Mahmooei B; Clapperton A; McClure R
    Aust N Z J Public Health; 2017 Feb; 41(1):85-91. PubMed ID: 27624336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pill problem: prescription drug abuse is the fastest growing form of substance abuse.
    Hanson K
    State Legis; 2010 Mar; 36(3):22-5. PubMed ID: 20306600
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription drug monitoring programs and death rates from drug overdose.
    Paulozzi LJ; Kilbourne EM; Desai HA
    Pain Med; 2011 May; 12(5):747-54. PubMed ID: 21332934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.
    Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M
    Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.
    Ringwalt C; Garrettson M; Alexandridis A
    J Prim Prev; 2015 Apr; 36(2):131-7. PubMed ID: 25466768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.